Sign In
Buy DARE
$2.05
-0.0900 (-4.21%)
At Close: Jun 03, 2026
Edited Transcript of DARE earnings conference call or presentation 30-Mar-20 8:30pm GMT
08:24pm, Wednesday, 08'th Apr 2020
Q4 2019 Dare Bioscience Inc Earnings Call
Dare Bioscience (NASDAQ:DARE) Receives New Coverage from Analysts at Maxim Group
07:18am, Thursday, 02'nd Apr 2020
Investment analysts at Maxim Group initiated coverage on shares of Dare Bioscience (NASDAQ:DARE) in a research note issued to investors on Wednesday, TipRanks reports. The brokerage set a “buy” ra
Analysts Offer Insights on Healthcare Companies: Avrobio (NASDAQ: AVRO), Dicerna Pharma (NASDAQ: DRNA) and Dar Bioscience (NASDAQ: DARE)
03:47pm, Wednesday, 01'st Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Avrobio (
AVRO
–
Research Report
), Dicerna Pharma (
DRNA
–
Research Report
) and Daré Bioscience
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, today announced it received a Notice of Award of $730,722 in a grant supporting the Ovaprene® postcoital test (PCT) clinical
Dare Bioscience Inc to Host Earnings Call
06:30pm, Monday, 30'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 30, 2020 / Dare Bioscience Inc (NASDAQ:DARE) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 30, 2020 at 4:30
Daré Bioscience Reports 2019 Financial Results and Provides a Company Update
12:00pm, Monday, 30'th Mar 2020
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, today reported financial results for the year ended December 31, 2019 and provided a company update. As a result of the COVID
The Week Ahead In Biotech: Clinical Readouts, COVID-19 News Flow In Focus Amid Continuing Uncertainty
04:10pm, Sunday, 29'th Mar 2020
After starting the week ended March 28 on the backfoot, biotech stocks recovered through the week. Activity in the space remained light, although coronavirus (COVID-19) news flow continued to dominate
How Much Are Daré Bioscience, Inc. (NASDAQ:DARE) Insiders Spending On Buying Shares?
01:45pm, Sunday, 29'th Mar 2020
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
SAN DIEGO, March 24, 2020 -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast.
ET, OXY among premarket gainers
01:22pm, Tuesday, 10'th Mar 2020
Ovintiv (NYSE:OVV) +67% after yesterday's 72% plunge.Cypress Semiconductor (NASDAQ:CY) +47% on received clearance from the Committee on Foreign Investment in the United States to be acquired by Ge
Daré Bioscience Receives FDA Fast Track Designation for DARE-BV1 for the Treatment of Bacterial Vaginosis
12:00pm, Tuesday, 10'th Mar 2020
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for DARE-BV1 for the treat
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, today announced the presentation of positive findings from a previously reported investigational study that used thermography
Daré Bioscience to Present at the Cowen 40th Annual Health Care Conference
01:00pm, Thursday, 27'th Feb 2020
SAN DIEGO, Feb. 27, 2020 -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, President and Chief.
Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO
09:05pm, Wednesday, 12'th Feb 2020
Anika Therapeutics, Inc. (ANIK) today announced that Dr. Cheryl Blanchard, a member of the Company’s Board of Directors since August 2018, has been named interim Chief Executive Officer, effective i
Daré Bioscience Regains Compliance with Nasdaq Minimum Equity Rule and Secures Capital to Advance Product Candidates
01:00pm, Thursday, 06'th Feb 2020
Daré Bioscience, Inc. (DARE), a leader in women’s health innovation, announced that it has been notified by The Nasdaq Stock Market LLC that the Company has regained compliance with the minimum st
